Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking | 38 | 2022 | 1452 | 4.320 |
Why?
|
Smoking Cessation | 33 | 2022 | 1034 | 3.640 |
Why?
|
Vaping | 15 | 2023 | 124 | 2.730 |
Why?
|
Nicotine | 20 | 2023 | 350 | 2.730 |
Why?
|
Tobacco Products | 12 | 2023 | 234 | 2.440 |
Why?
|
Tobacco Use Disorder | 14 | 2023 | 432 | 2.370 |
Why?
|
Electronic Nicotine Delivery Systems | 16 | 2023 | 180 | 2.180 |
Why?
|
Smokers | 16 | 2022 | 200 | 2.100 |
Why?
|
Motivation | 15 | 2021 | 561 | 1.770 |
Why?
|
Economics, Behavioral | 3 | 2020 | 12 | 1.500 |
Why?
|
Cross-Cultural Comparison | 5 | 2019 | 68 | 1.290 |
Why?
|
Behavior, Addictive | 4 | 2020 | 317 | 1.230 |
Why?
|
Affect | 3 | 2015 | 218 | 0.880 |
Why?
|
Cues | 6 | 2020 | 654 | 0.850 |
Why?
|
Smoking Prevention | 5 | 2022 | 259 | 0.840 |
Why?
|
Adaptation, Psychological | 4 | 2018 | 447 | 0.830 |
Why?
|
Adult | 50 | 2023 | 21403 | 0.760 |
Why?
|
Delay Discounting | 2 | 2018 | 7 | 0.740 |
Why?
|
Pain | 7 | 2023 | 472 | 0.720 |
Why?
|
Social Values | 2 | 2019 | 34 | 0.700 |
Why?
|
Health Surveys | 7 | 2019 | 489 | 0.660 |
Why?
|
Self Efficacy | 5 | 2017 | 199 | 0.620 |
Why?
|
Self-Control | 2 | 2017 | 9 | 0.620 |
Why?
|
Young Adult | 24 | 2020 | 5717 | 0.590 |
Why?
|
Craving | 3 | 2020 | 200 | 0.570 |
Why?
|
Canada | 8 | 2022 | 267 | 0.530 |
Why?
|
Male | 47 | 2021 | 37321 | 0.530 |
Why?
|
Models, Psychological | 1 | 2017 | 180 | 0.530 |
Why?
|
Female | 47 | 2023 | 38074 | 0.530 |
Why?
|
Middle Aged | 34 | 2021 | 21147 | 0.500 |
Why?
|
Humans | 60 | 2023 | 68618 | 0.490 |
Why?
|
Australia | 7 | 2019 | 235 | 0.480 |
Why?
|
Nicotinic Agonists | 4 | 2019 | 111 | 0.470 |
Why?
|
Health Behavior | 6 | 2021 | 458 | 0.470 |
Why?
|
Surveys and Questionnaires | 12 | 2019 | 2800 | 0.430 |
Why?
|
Adolescent | 17 | 2020 | 8912 | 0.410 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 2279 | 0.410 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2021 | 435 | 0.410 |
Why?
|
England | 6 | 2019 | 64 | 0.370 |
Why?
|
Consumer Behavior | 3 | 2020 | 68 | 0.370 |
Why?
|
Tobacco Smoking | 3 | 2021 | 41 | 0.360 |
Why?
|
Recurrence | 5 | 2021 | 948 | 0.350 |
Why?
|
Tobacco | 5 | 2023 | 161 | 0.310 |
Why?
|
Social Environment | 2 | 2020 | 182 | 0.310 |
Why?
|
Prospective Studies | 6 | 2023 | 3705 | 0.280 |
Why?
|
United States | 10 | 2021 | 7367 | 0.270 |
Why?
|
Longitudinal Studies | 5 | 2023 | 1054 | 0.260 |
Why?
|
Commerce | 3 | 2020 | 80 | 0.250 |
Why?
|
Aged | 13 | 2021 | 14862 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2016 | 767 | 0.240 |
Why?
|
Netherlands | 3 | 2019 | 68 | 0.240 |
Why?
|
Attitude to Health | 4 | 2019 | 403 | 0.230 |
Why?
|
Flavoring Agents | 2 | 2022 | 24 | 0.220 |
Why?
|
Stress, Psychological | 2 | 2020 | 824 | 0.210 |
Why?
|
Students | 2 | 2016 | 233 | 0.210 |
Why?
|
Quinoxalines | 2 | 2014 | 78 | 0.200 |
Why?
|
Benzazepines | 2 | 2014 | 104 | 0.200 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 193 | 0.200 |
Why?
|
Tobacco Use | 2 | 2021 | 98 | 0.190 |
Why?
|
Tobacco Industry | 1 | 2021 | 55 | 0.180 |
Why?
|
Propylene Glycol | 1 | 2020 | 5 | 0.180 |
Why?
|
Taxes | 1 | 2020 | 31 | 0.180 |
Why?
|
Glycerol | 1 | 2020 | 26 | 0.180 |
Why?
|
United Kingdom | 2 | 2017 | 152 | 0.180 |
Why?
|
Emotions | 2 | 2012 | 244 | 0.180 |
Why?
|
Vegetables | 1 | 2020 | 76 | 0.170 |
Why?
|
Public Policy | 2 | 2017 | 71 | 0.170 |
Why?
|
Smoke-Free Policy | 1 | 2019 | 8 | 0.170 |
Why?
|
Public Health | 1 | 2021 | 201 | 0.160 |
Why?
|
Intention | 2 | 2017 | 80 | 0.160 |
Why?
|
Professional-Patient Relations | 1 | 2019 | 71 | 0.160 |
Why?
|
Marketing | 1 | 2018 | 26 | 0.160 |
Why?
|
Cigarette Smoking | 1 | 2020 | 104 | 0.160 |
Why?
|
Psychomotor Performance | 1 | 2019 | 213 | 0.150 |
Why?
|
Marijuana Smoking | 1 | 2019 | 108 | 0.150 |
Why?
|
Reward | 3 | 2018 | 201 | 0.140 |
Why?
|
Time Factors | 4 | 2018 | 4655 | 0.140 |
Why?
|
Pain Perception | 1 | 2016 | 22 | 0.140 |
Why?
|
Health Policy | 1 | 2018 | 221 | 0.140 |
Why?
|
Health Education | 1 | 2019 | 279 | 0.140 |
Why?
|
Fatigue | 1 | 2017 | 132 | 0.130 |
Why?
|
Pain Threshold | 1 | 2016 | 55 | 0.130 |
Why?
|
Social Stigma | 1 | 2016 | 53 | 0.130 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 438 | 0.130 |
Why?
|
Databases, Factual | 1 | 2018 | 622 | 0.130 |
Why?
|
Treatment Outcome | 6 | 2017 | 7029 | 0.130 |
Why?
|
Analgesics | 1 | 2016 | 118 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 782 | 0.120 |
Why?
|
Double-Blind Method | 5 | 2020 | 1738 | 0.120 |
Why?
|
Health Status Disparities | 1 | 2017 | 326 | 0.120 |
Why?
|
Prevalence | 4 | 2021 | 1619 | 0.110 |
Why?
|
Pilot Projects | 4 | 2020 | 1342 | 0.110 |
Why?
|
Cognitive Dissonance | 1 | 2013 | 4 | 0.110 |
Why?
|
Patient Satisfaction | 1 | 2016 | 378 | 0.110 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 41 | 0.110 |
Why?
|
Therapy, Computer-Assisted | 1 | 2013 | 57 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2012 | 32 | 0.100 |
Why?
|
Object Attachment | 1 | 2012 | 20 | 0.100 |
Why?
|
Ganglionic Stimulants | 1 | 2012 | 15 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2012 | 127 | 0.100 |
Why?
|
Implosive Therapy | 1 | 2013 | 171 | 0.100 |
Why?
|
Self Report | 1 | 2013 | 371 | 0.100 |
Why?
|
Social Behavior | 1 | 2012 | 164 | 0.090 |
Why?
|
Inpatients | 1 | 2012 | 208 | 0.090 |
Why?
|
Central Nervous System Depressants | 1 | 2012 | 182 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2012 | 209 | 0.090 |
Why?
|
Florida | 1 | 2011 | 221 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 627 | 0.090 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 1242 | 0.090 |
Why?
|
Choice Behavior | 2 | 2020 | 85 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2012 | 805 | 0.070 |
Why?
|
Ethanol | 1 | 2012 | 893 | 0.070 |
Why?
|
Sex Factors | 2 | 2020 | 1266 | 0.060 |
Why?
|
Social Class | 2 | 2017 | 127 | 0.060 |
Why?
|
Universities | 2 | 2016 | 191 | 0.060 |
Why?
|
Internet | 2 | 2018 | 390 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 1745 | 0.050 |
Why?
|
Varenicline | 2 | 2014 | 98 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 2077 | 0.050 |
Why?
|
Workplace | 1 | 2021 | 75 | 0.050 |
Why?
|
Solvents | 1 | 2020 | 109 | 0.040 |
Why?
|
Dual Use Research | 1 | 2019 | 2 | 0.040 |
Why?
|
Social Marketing | 1 | 2019 | 33 | 0.040 |
Why?
|
Geography | 1 | 2019 | 80 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2019 | 106 | 0.040 |
Why?
|
Tobacco Use Cessation | 1 | 2018 | 44 | 0.040 |
Why?
|
Educational Status | 1 | 2019 | 273 | 0.040 |
Why?
|
Mauritius | 1 | 2017 | 3 | 0.040 |
Why?
|
Thailand | 1 | 2017 | 28 | 0.040 |
Why?
|
Mexico | 1 | 2017 | 38 | 0.040 |
Why?
|
Cannabis | 1 | 2019 | 115 | 0.040 |
Why?
|
Forecasting | 1 | 2018 | 277 | 0.040 |
Why?
|
Saliva | 1 | 2017 | 142 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2016 | 260 | 0.030 |
Why?
|
Chronic Pain | 1 | 2016 | 110 | 0.030 |
Why?
|
Decision Making | 1 | 2018 | 410 | 0.030 |
Why?
|
Comorbidity | 1 | 2019 | 1426 | 0.030 |
Why?
|
Qualitative Research | 1 | 2016 | 369 | 0.030 |
Why?
|
Placebo Effect | 1 | 2014 | 20 | 0.030 |
Why?
|
South Carolina | 1 | 2021 | 2752 | 0.030 |
Why?
|
Age Factors | 1 | 2019 | 1864 | 0.030 |
Why?
|
Diet Therapy | 1 | 2013 | 22 | 0.030 |
Why?
|
Cotinine | 1 | 2013 | 40 | 0.030 |
Why?
|
Psychotherapy, Group | 1 | 2013 | 55 | 0.030 |
Why?
|
Occupations | 1 | 2012 | 27 | 0.030 |
Why?
|
Gene Frequency | 1 | 2013 | 207 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2016 | 1553 | 0.030 |
Why?
|
Perception | 1 | 2014 | 189 | 0.030 |
Why?
|
Alcoholic Beverages | 1 | 2012 | 18 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 44 | 0.030 |
Why?
|
Facial Expression | 1 | 2012 | 36 | 0.030 |
Why?
|
Linear Models | 1 | 2014 | 521 | 0.030 |
Why?
|
Southeastern United States | 1 | 2012 | 281 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 442 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2013 | 425 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2012 | 269 | 0.020 |
Why?
|
Personality Inventory | 1 | 2010 | 197 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 7277 | 0.020 |
Why?
|
Chronic Disease | 1 | 2010 | 1330 | 0.020 |
Why?
|